The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...
Thanks to predictive and preventive medicine. The global immunoassay market is projected to grow by $8.64b until 2028 at a compound annual growth rate of 4.42%, said Technavio. The sector’s ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Beckman Coulter Diagnostics' new DxC 500i Clinical Analyzer. The integrated clinical chemistry and immunoassay analyser claims ...
Ahomebrewbead-based immunoassay begins with the capture and labeling of an analyte using an enzyme conjugate (streptavidin ß-galactosidase, SBG). The analyte is captured with beads, and a ...